Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack

This study has been terminated.
Sponsor:
Information provided by:
Arginox Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00112281
First received: June 1, 2005
Last updated: August 2, 2006
Last verified: May 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: January 2007
  Estimated Primary Completion Date: No date given
No publications provided by Arginox Pharmaceuticals

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):